| Chlorambucil plus rituximab with or without maintenance rituximab as first‐line treatment for elderly chronic lymphocytic leukemia patients R Foà, I Del Giudice, A Cuneo, G Del Poeta, S Ciolli, F Di Raimondo, ... American journal of hematology 89 (5), 480-486, 2014 | 147 | 2014 |
| Quantitative PCR of bone marrow BCL2/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphoma A Rambaldi, E Carlotti, E Oldani, ID Starza, M Baccarani, S Cortelazzo, ... Blood 105 (9), 3428-3433, 2005 | 134 | 2005 |
| Minimal residual disease in acute lymphoblastic leukemia: technical and clinical advances I Della Starza, S Chiaretti, MS De Propris, L Elia, M Cavalli, LA De Novi, ... Frontiers in oncology 9, 726, 2019 | 127 | 2019 |
| Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: the FIL FOLL05 trial S Galimberti, S Luminari, E Ciabatti, S Grassi, F Guerrini, A Dondi, ... Clinical Cancer Research 20 (24), 6398-6405, 2014 | 125 | 2014 |
| Comparative analysis between RQ‐PCR and digital‐droplet‐PCR of immunoglobulin/T‐cell receptor gene rearrangements to monitor minimal residual disease in acute lymphoblastic … I Della Starza, V Nunes, M Cavalli, LA De Novi, C Ilari, V Apicella, A Vitale, ... British Journal of Haematology 174 (4), 541-549, 2016 | 80 | 2016 |
| Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented … S Chiaretti, M Messina, I Della Starza, A Piciocchi, L Cafforio, M Cavalli, ... haematologica 106 (6), 1559, 2020 | 71 | 2020 |
| Minimal residual disease in chronic lymphocytic leukemia: a new goal? I Del Giudice, S Raponi, I Della Starza, MS De Propris, M Cavalli, ... Frontiers in oncology 9, 689, 2019 | 66 | 2019 |
| Partial deletions of long arm of chromosome 6: biologic and clinical implications in adult acute lymphoblastic leukemia M Mancini, ML Vegna, GL Castoldi, C Mecucci, F Spirito, L Elia, A Tafuri, ... Leukemia 16 (10), 2055-2061, 2002 | 62 | 2002 |
| Immunoglobulin gene rearrangements in Chinese and Italian patients with chronic lymphocytic leukemia M Marinelli, C Ilari, Y Xia, I Del Giudice, L Cafforio, I Della Starza, ... Oncotarget 7 (15), 20520, 2016 | 55 | 2016 |
| Comparative analysis between RQ‐PCR and digital droplet PCR of BCL2/IGH gene rearrangement in the peripheral blood and bone marrow of early stage … M Cavalli, LA De Novi, I Della Starza, LV Cappelli, V Nunes, A Pulsoni, ... British Journal of Haematology 177 (4), 588-596, 2017 | 54 | 2017 |
| Droplet digital PCR quantification of mantle cell lymphoma follow-up samples from four prospective trials of the European MCL Network D Drandi, M Alcantara, I Benmaad, A Söhlbrandt, L Lhermitte, ... Hemasphere 4 (2), e347, 2020 | 52 | 2020 |
| Histopathological and molecular features of persistent polyclonal B‐cell lymphocytosis (PPBL) with progressive splenomegaly I Del Giudice, SA Pileri, M Rossi, E Sabattini, C Campidelli, ID Starza, ... British journal of haematology 144 (5), 726-731, 2009 | 42 | 2009 |
| Minimal residual disease monitoring in chronic lymphocytic leukaemia patients. A comparative analysis of flow cytometry and ASO IgH RQ‐PCR S Raponi, I Della Starza, MS De Propris, I Del Giudice, FR Mauro, ... British journal of haematology 166 (3), 360-368, 2014 | 40 | 2014 |
| Droplet digital PCR improves IG-/TR-based MRD risk definition in childhood B-cell precursor acute lymphoblastic leukemia I Della Starza, V Nunes, F Lovisa, D Silvestri, M Cavalli, A Garofalo, ... Hemasphere 5 (3), e543, 2021 | 32 | 2021 |
| Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric‐like GIMEMA LAL‐1308 trial AM Testi, M Canichella, A Vitale, A Piciocchi, A Guarini, ID Starza, ... American Journal of Hematology 96 (3), 292-301, 2021 | 32 | 2021 |
| Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemia I Della Starza, LA De Novi, A Santoro, D Salemi, W Tam, M Cavalli, ... Leukemia & Lymphoma, 2019 | 31 | 2019 |
| Stage I/II follicular lymphoma: spread of bcl‐2/IgH+ cells in blood and bone marrow from primary site of disease and possibility of clearance after involved field radiotherapy A Pulsoni, ID Starza, N Frattarelli, E Ghia, E Carlotti, E Cavalieri, ... British journal of haematology 137 (3), 216-220, 2007 | 28 | 2007 |
| Minimal residual disease monitoring in early stage follicular lymphoma can predict prognosis and drive treatment with rituximab after radiotherapy A Pulsoni, I Della Starza, LV Cappelli, ME Tosti, G Annechini, M Cavalli, ... British Journal of Haematology 188 (2), 249-258, 2020 | 23 | 2020 |
| Clinical significance of occult central nervous system disease in adult acute lymphoblastic leukemia: a multicenter report from the Campus ALL Network MI Del Principe, E Buzzatti, A Piciocchi, F Forghieri, M Bonifacio, F Lessi, ... Haematologica 106 (1), 39, 2019 | 23 | 2019 |
| Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations S Raponi, C Ilari, I Della Starza, LV Cappelli, L Cafforio, A Piciocchi, ... British Journal of Haematology 189 (5), 853-859, 2020 | 22 | 2020 |
